Search Tag: Oncology Research

2024 01 Oct

  AOP Orphan Pharmaceuticals GmbH (AOP Health) in collaboration with Leukos Biotech has achieved a key milestone. The first patient was included in the phase I clinical trial SERONCO-1, in which a substance with a new and unique mechanism of action (first-in-class) is being investigated. The drug candidate is being studied in patients with solid...Read more

2024 06 Aug

  A new therapeutic approach to fight cancer   With the approval of its Phase-1 clinical trial SERONCO-1, AOP Health has reached another milestone in its growth story. To mark the start of the trial at Vall d’Hebron University Hospital in Barcelona AOP Health hosted a panel discussion in collaboration with the daily Austrian newspaper “Der Standard”...Read more

2024 10 Jun

  Hematology/oncology: AOP Health’s expanding clinical research program delivers new results.   AOP Orphan Pharmaceuticals GmbH (AOP Health) continues a successful clinical research program in hematology/oncology with two abstracts accepted for presentation at the European Hematology Association (EHA) 2024 hybrid congress in Madrid, Spain....Read more

2024 29 May

  Microwave lung ablation (MWA) is a method for removing lung tumours with low risk and cost compared to surgery. However, it faces challenges like incomplete tumour removal due to difficulty in achieving sufficient margins. Existing methods for planning MWA based on vendor models often result in discrepancies between planned and actual outcomes....Read more

2024 28 May

  Renal cell carcinoma (RCC) is a significant global health issue, constituting a sizable portion of cancer cases and presenting challenges in early detection due to its asymptomatic nature. Imaging techniques like CT and MRI are crucial for diagnosing and staging RCC, but they may miss small or low-grade metastatic lesions. As a result, there's...Read more

2024 17 May

Oesophageal cancer (EC) is a growing concern globally, with multidisciplinary treatments offering the best chance of cure. However, despite advancements, the 5-year survival rate remains low. Accurate staging is crucial for treatment decisions, but current methods like endoscopic ultrasound (EUS) have limitations, leading to overestimation of tumour...Read more